Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
3
×
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national
national blog main
3
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
aduro biotech
biogen
cancer immunotherapy
clinical trials
crispr
deals
drug prices
glaxosmithkline
What
bio
companies
3
×
roundup
drug
price
alzheimer’s
approval
biogen’s
biopharmaceutical
black
continue
convo
debut
diamond
diamond’s
different
earlier
fail
failures
gene
increases
indication
latest
leading
life
littered
mammoth
march
moves
nash
new
news
ohana’s
pharmaceutical
plan
pop
prescription
prices
raise
remains
Language
unset
Current search:
companies
×
cancer
×
" alzheimer's disease "
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More